09.08.2024 | Tracker
Top 50 Pharma Tracker: HCPs excited by Moderna-Merck cancer vaccine
By Aman Jandu The Top 50 Pharmaceutical Companies mentioned by eHCPs on X
| July Rank | June Rank | Company Name | Total Mentions | Account Mentions | Account Retweets |
|---|---|---|---|---|---|
| 1 | 1 | Pfizer | 2,107 | 206 | 3 |
| 2 | 2 | Moderna | 1,712 | 64 | 15 |
| 3 | 7 | Gilead Sciences | 576 | 193 | 5 |
| 4 | 5 | GSK | 545 | 124 | 21 |
| 5 | 3 | Johnson & Johnson | 501 | 48 | 3 |
| 6 | 11 | Lilly | 340 | 78 | 4 |
| 7 | 4 | AstraZeneca | 326 | 115 | 9 |
| 8 | 12 | Roche | 246 | 61 | 13 |
| 9 | 8 | Novavax | 243 | 32 | 6 |
| 10 | 10 | Bayer | 224 | 97 | 3 |
| 11 | 9 | Novo Nordisk | 201 | 90 | 15 |
| 12 | 14 | Sanofi | 175 | 53 | 0 |
| 13 | 16 | Merck & Co | 149 | 38 | 8 |
| 14 | 13 | Abbott | 127 | 103 | 8 |
| 15 | 23 | Fresenius | 89 | 75 | 4 |
| 16 | 18 | Otsuka | 88 | 21 | 1 |
| 17 | 17 | Novartis | 84 | 34 | 3 |
| 18 | 6 | AbbVie | 69 | 54 | 12 |
| 19 | 19 | Boehringer Ingelheim | 59 | 47 | 1 |
| 20 | 25 | Daiichi Sankyo | 56 | 19 | 0 |
| 21 | 32 | Teva | 55 | 3 | 0 |
| 22 | 36 | Biogen | 46 | 21 | 0 |
| 23 | 22 | Organon | 44 | 0 | 0 |
| 24 | 36 | Eisai | 41 | 16 | 0 |
| 25 | 21 | Amgen | 39 | 15 | 1 |
| 26 | 26 | Chugai | 36 | 4 | 4 |
| 27 | 29 | Regeneron | 35 | 26 | 0 |
| 28 | 15 | Takeda | 30 | 24 | 0 |
| 29 | 20 | BMS | 26 | 19 | 0 |
| 30 | 28 | STADA Arneimittel | 25 | 2 | 0 |
| 31 | 26 | Merck KGaA | 22 | 22 | 9 |
| 32 | 36 | Bausch | 21 | 9 | 2 |
| 33 | 30 | Vertex | 16 | 14 | 1 |
| 33 | 43 | Servier | 16 | 10 | 9 |
| 35 | 40 | Ipsen | 15 | 11 | 0 |
| 36 | 41 | Sun | 12 | 5 | 2 |
| 37 | 24 | UCB | 11 | 5 | 2 |
| 38 | 32 | Jazz Pharmaceuticals | 8 | 3 | 0 |
| 39 | 31 | Astellas | 7 | 2 | 0 |
| 39 | 39 | CSL | 7 | 7 | 0 |
| 41 | 35 | Viatris | 6 | 0 | 0 |
| 42 | 45 | Dr. Reddy's Labratories | 5 | 0 | 0 |
| 43 | 43 | Menarini | 4 | 1 | 1 |
| 44 | 34 | Incyte | 3 | 2 | 0 |
| 44 | 42 | Grifols | 3 | 0 | 0 |
| 50 | 46 | Jiangsu Hengrui | 0 | 0 | 0 |
| 50 | 50 | Shanghai | 0 | 0 | 0 |
| 50 | 50 | Sino | 0 | 0 | 0 |
| 50 | 50 | Yunnan Baiyao Group | 0 | 0 | 0 |
| 50 | 50 | Mitsubishi Chemical Group | 0 | 0 | 0 |
July’s insights from eHCPs mentioning the Top 50 Pharmaceutical Companies
The five most mentioned pharmaceutical companies by eHCPs on X in July 2024 were Pfizer, Moderna, Gilead, GSK and Johnson & Johnson.
CREATION.co identified 7,696 eHCP mentions of pharmaceutical companies in July 2024, decreasing by 26.2% compared to the previous month.
On 03 July, eHCPs celebrated Eli Lilly’s FDA approval of donanemab for the treatment of Alzheimer’s disease, part of a new horizon in monoclonal antibodies. Professor Norio Nakatsuji shared a post by the California Institute for Regenerative Medicine celebrating the achievement, who calling the approval “thrilling” and celebrating the researchers involved.
#CIRM is thrilled about the @US_FDA approval of @EliLillyandCo's Kisunla for early symptomatic #Alzheimers! This underscores the importance of continued research in neurodegenerative diseases. Congrats to all researchers involved! #MedicalProgresshttps://t.co/OvIdda1Nku
— California Institute for Regenerative Medicine (@CIRMnews) July 3, 2024
On 18 July, Peter Diamandis, MD – an entrepreneur and chairman of X Prize – shared his blog to celebrate the progress of the Moderna-Merck collaboration on a cancer vaccine – calling it a “gamechanger” for cancer patients.
Read about the top 3 science and tech breakthroughs currently on my mind in this week’s Abundance Blog: https://t.co/5SNLeWTKZ0
— Peter H. Diamandis, MD (@PeterDiamandis) July 18, 2024
On the same day, Dr Brian Kim thanked Sanofi for supporting him and his colleagues in an initiative to recognise neuroimmunology as a therapeutic paradigm. The initiative led to teachers from schools in underserved communities meeting with HCPs to inspire the next generation of scientists.
Great to see you @RazaZaheerYYZ and thanks to you and @sanofi @SanofiUS for supporting what we do and being one of the first #pharma companies to truly embrace #neuroimmunology as a major paradigm of #therapeutics pic.twitter.com/X5etMV2ize
— Brian S. Kim (@itchdoctor) July 18, 2024
The Allen Discovery Center for Neuroimmune Interactions (ADCNI) hosted a coffee chat for #science teachers from high schools in several #NYC underserved communities. Hongzhen Hu and I both shared the science and #discoveries that are underway at ADCNI. In an inspiring exchange,… pic.twitter.com/LpLzvoFnBq
— Brian S. Kim (@itchdoctor) July 18, 2024
The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:
- An article discussing the price of Gilead’s HIV vaccine.
- An article discussing the FDA approval of Eli Lilly-s Alzheimer’s treatment.
- A Telegram link for a scientific article evaluating physical examination against imaging.
——
Find out how the conversation is changing in other Top 50 Trackers and new analysis of the online HCP conversation in a variety of topics.
You can also receive these updates and more straight to your inbox by signing up to CREATION.co’s monthly eJournal.
Methodology notes:
- In July 2024, CREATION Pinpoint® identified 7,696 posts on X (Twitter) from 3,569 individual eHCPs mentioning a Top 50 Pharmaceutical company (based on revenue).
- Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 31 July 2024.
- Unless otherwise specified, mentions of a company are not limited to its X account(s).
- In some cases, a post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Johnson & Johnson Innovative Medicine (previously Janssen). In July 2024, 39 of these posts mentioned Johnson & Johnson Innovative Medicine or Janssen.
